Spiderwort Biotechnologies Inc. is a clinical stage company developing plant-derived cellulose biomaterials for use as scaffolds in a number of tissue engineering applications, ultimately aiming to increase and enhance patients’ treatment options and quality of life. The two lead applications of its Aerocell platform technology target regeneration after spinal cord injury (CelluBridge®) and soft tissue augmentation (CelluJuve®) as dermal fillers.